Taipei, Friday, February 24, 2017 20:31 (GMT+8)
showers
Taipei
17°C
PCB maker Apex to see capacity utilization rate drop to 80% in 4Q12 - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Thursday 11 October 2012]
  • APEX Medical
  • Performance
    The company's stock price closed at NT$32.65 on the TSE on Thursday, February 23, 2017.
    The company has reported consolidated revenues of NT$131 million for January 2017, representing a 35% drop on month and 33.2% drop on year.
    For the third quarter of 2016, the company totaled NT$430 million in consolidated revenues, down 18.4% sequentially and up 2.8% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    24-Feb 289 211 9,531,388 32.65 33.35 32.65 33.30+0.65+1.99% 33.25 33.30
    23-Feb 346 205 11,367,633 33.00 33.20 32.65 32.65-0.35-1.06% 32.65 32.70
    22-Feb 248 173 8,243,926 33.40 33.60 33.00 33.00-0.45-1.35% 33.00 33.20
    21-Feb 174 110 5,808,959 33.60 33.60 33.20 33.45-0.15-0.45% 33.30 33.45
    20-Feb 331 198 11,087,559 33.70 33.75 33.20 33.60+0.00+0.00% 33.40 33.60
    18-Feb 581 328 19,525,808 33.60 33.80 33.30 33.60+0.30+0.90% 33.60 33.65
    17-Feb 205 154 6,832,677 33.40 33.60 33.25 33.30-0.05-0.15% 33.30 33.45
    16-Feb 413 263 13,825,858 33.30 33.80 33.25 33.35+0.05+0.15% 33.35 33.45
    15-Feb 107 82 3,562,569 33.10 33.30 33.10 33.30-0.10-0.30% 33.15 33.30
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Jan 2016 - Jan 2017 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Jan-17

    131

    (35%)

    (33.2%)

    131

    (33.2%)

    Dec-16

    202

    21.6%

    2.1%

    1,989

    (1.4%)

    Nov-16

    166

    6.6%

    2.8%

    1,787

    (1.8%)

    Oct-16

    156

    13.8%

    (8.4%)

    1,621

    (2.3%)

    Sep-16

    137

    (10.3%)

    (7%)

    1,465

    (1.5%)

    Aug-16

    153

    9.2%

    15.7%

    1,327

    (1%)

    Jul-16

    140

    (20%)

    (0.7%)

    1,175

    (2.8%)

    Jun-16

    175

    1.6%

    (11.1%)

    1,035

    (3%)

    May-16

    172

    (4.2%)

    0.4%

    860

    (1.2%)

    Apr-16

    179

    1.5%

    (1.1%)

    688

    (1.6%)

    Mar-16

    177

    31.2%

    (20%)

    509

    (1.8%)

    Feb-16

    135

    (31.5%)

    (8.4%)

    332

    11.8%

    Jan-16

    197

    (0.6%)

    31.7%

    197

    31.7%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2017

    Apex: Consolidated revenues, 3Q15 - 3Q16 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    3Q-16

    430

    (18.4%)

    2.8%

    1,465

    (1.5%)

    2Q-16

    526

    3.5%

    (4.5%)

    1,035

    (3.1%)

    1Q-16

    509

    (4%)

    (1.6%)

    509

    (1.6%)

    4Q-15

    530

    26.7%

    (2.4%)

    2,016

    (10.9%)

    3Q-15

    418

    (24.1%)

    (24.6%)

    1,486

    (13.6%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2017

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 3Q15 - 3Q16 (NT$k)

    Item

    3Q-2016

    2Q-2016

    1Q-2016

    4Q-2015

    3Q-2015

    Current assets

    1,108,550

    1,192,820

    1,228,009

    1,275,623

    1,319,701

    Intangible assets

    445,656

    467,711

    491,597

    514,677

    530,132

    Non-current assets

    1,318,301

    1,360,602

    1,392,912

    1,225,181

    1,257,081

    Assets

    2,426,851

    2,553,422

    2,620,921

    2,500,804

    2,576,782

    Current liabilities

    869,126

    967,005

    936,015

    826,220

    970,826

    Non-current liabilities

    5,427

    5,479

    5,595

    3,832

    1,846

    Liabilities

    874,553

    972,484

    941,610

    830,052

    972,672

    Stockholders' equity

    1,552,298

    1,580,938

    1,679,311

    1,670,752

    1,604,110

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2017

    Apex: Consolidated income statement, 3Q15 - 3Q16 (NT$k)

    Item

    3Q-2016

    2Q-2016

    1Q-2016

    4Q-2015

    3Q-2015

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

     

     

    508,572

     

    0

     

     

     

    Operating revenue

    429,703

    84.5%

    526,243

    103.5%

    508,572

    100%

    529,887

     

    418,107

    97.3%

    Gross profit (loss) from operations

    192,185

    37.8%

    240,584

    47.3%

    227,879

    44.8%

    239,903

    45.3%

    185,490

    43.2%

    Operating expenses

    167,287

    32.9%

    190,327

    37.4%

    172,372

    33.9%

    188,905

    35.7%

    174,947

    40.7%

    Operating income (loss)

    24,898

    4.9%

    50,257

    9.9%

    55,507

    10.9%

    50,998

    9.6%

    10,543

    2.5%

    Non-operating expenses and losses

    3,988

    0.8%

    2,769

    0.5%

    4,455

    0.9%

    5,830

    1.1%

    5,329

    1.2%

    Income from continuing operations before income tax

    28,886

    5.7%

    53,026

    10.4%

    59,962

    11.8%

    56,828

    10.7%

    15,872

    3.7%

    Net income (loss)

    26,264

    5.2%

    33,766

    6.6%

    47,033

    9.2%

    46,990

    8.9%

    14,049

    3.3%

    Diluted earnings per share (NT$)

    0.3

     

    0.4

     

    0.6

     

    0.6

     

    0.2

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2017

  • APEX Medical full profile

24-Feb-2017 markets closed

 LastChange

TAIEX (TSE)9750.47-18.84-0.19% 

TSE electronic394.1-0.47-0.12% 

GTSM (OTC)134.77+0.09+0.07% 

OTC electronic188-0.27-0.14% 

Advantest
Wireless broadband developments in Southeast Asia markets
Analysis of China revised domestic semiconductor industry goals
  • The 10nm competition

    TSMC and Samsung have been competing for clients for the 10nm node.

  • Japan earthquake

    Earthquakes in Japan often cause huge damage. They have had strong impacts on the country's electronics industry.

  • China: Big plans for homegrown chips

    A CNY120 billion (US$19 billion) national industry investment fund has been set up to help local foundries finance the build-up of advanced manufacturing...

  • ASE seeking to take up major stake in SPIL

    Advanced Semiconductor Engineering (ASE) is seeking to acquire an up to 25% stake in fellow packaging house Siliconware Precision Industries (SPIL).

  • Wireless broadband developments in Southeast Asia markets

    As of 2013, the 10 ASEAN nations had a total of over 700 million mobile subscriptions, with the CAGR from 2003-2013 reaching 24%. This Digitimes Research Special Report analyzes the various mobile broadband markets in ASEAN and looks at the respective trends in 4G LTE development for those markets.

  • 2015 global tablet demand forecast

    This Digitimes Research Special Report provides a 2015 forecast for the global tablet market and analyzes the strategies of key market players such as Google, Apple, Intel, and Microsoft.

  • 2015 China smartphone panel trend forecast

    This Digitimes Research Special Report analyzes the strategies of key China-based major panel makers BOE, Tianma and IVO for attacking the different market segments through technology and pricing, and their relationship to local vendors Huawei, Lenovo, ZTE, Xiaomi and Coolpad.